Levocarnitine's role in the treatment of patients with end-stage renal disease: A review

Dialysis and Transplantation

Volumn 30, Issue 8, 2001, Pages 530-539

  Goral, S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE;

BLOOD LEVEL; CARDIOMYOPATHY; CARNITINE DEFICIENCY; DIALYSIS; DIET SUPPLEMENTATION; DRUG EFFECT; HEART ARRHYTHMIA; HUMAN; KIDNEY FAILURE; MALAISE; MUSCLE LEVEL; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SYMPTOMATOLOGY;

EID: 0034909115     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Morbidity and mortality of renal dialysis: An NIH consensus conference statement
2. Carnitine in renal failure
3. Carnitine deficiency syndromes
4. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart
5. Carnitine deficiency induced during intermittent haemodialysis for renal failure
6. Carnitine metabolism and usage in chronic dialysis patients
7. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure
8. L-carnitine administration to hemodialysis patients: Has its time come?
9. Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency
10. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects
11. Carnitine kinetics during dialysis. Evidence of unilateral transport from tissues to plasma
12. The role of L-carnitine in the pathogenesis and cardiomegaly in patients with chronic hemodialysis
13. Carnitine metabolism during exercise in patients on chronic hemodialysis
14. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients
15. Carnitine and lipid metabolism in Japanese uremic patients with continuous peritoneal dialysis
16. Low carnitine levels in hemodialysis patients: Relationship with functional activity status and intra-dialytic hypotension
17. Cardiac carnitine deficiency and altered carnitine transport in cardiomyopathic hamsters
18. Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemically induced cardiac insufficiency
19. Diabetic cardiomyopathy and carnitine deficiency
20. Effect of L-carnitine on myocardial metabolism: Results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery
21. Effects of L-carnitine on left ventricular remodeling after acute anterior myocardial infarction: The L-carnitine ecocardiografia digitalizzata infarto miocardico (CEDIM) trial
22. Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis
23. Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients
24. The response to recombinant human erythropoietin in patients with anemia of end-stage renal disease is correlated with serum carnitine levels
25. Effects of L-carnitine on arrhythmias during hemodialysis
26. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients
27. Carnitine and weakness in haemodialysis patients
28. Quality of life during and between hemodialysis treatments: Role of L-carnitine supplementation
29. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients
30. L-carnitine and haemodialysis: Double-blind study on muscle function and metabolism and peripheral nerve function
31. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects
32. Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle
33. Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers
34. Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis
35. Levocarnitine and muscle metabolism in patients with end-stage renal disease
36. Effect of carnitine supplementation on cardiac function in hemodialyzed children
37. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin
38. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis
39. Serum and muscle L-carnitine levels in hemodialyzed patients, during and after long-term L-carnitine treatment
40. L-carnitine for maintenance dialysis patients
41. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients